Cargando…
Microwave ablation is superior to radiofrequency ablation in the treatment of hepatocellular carcinoma below 5 cm - A systematic review and meta-analysis
The purpose of this study was to systematically evaluate the prognosis of patients with hepatocellular carcinoma (HCC) smaller than 5 cm using microwave ablation (MWA) versus radiofrequency ablation (RFA). PubMed, Cochrane Library and Embase databases were searched for studies reporting comparisons...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695319/ https://www.ncbi.nlm.nih.gov/pubmed/37706417 http://dx.doi.org/10.4103/jmas.jmas_344_22 |
_version_ | 1785153542862929920 |
---|---|
author | Zhang, Lingkai Du, Fei Zhang, Yongxuan Yangdan, Cairang Wang, Haijiu Ren, Li |
author_facet | Zhang, Lingkai Du, Fei Zhang, Yongxuan Yangdan, Cairang Wang, Haijiu Ren, Li |
author_sort | Zhang, Lingkai |
collection | PubMed |
description | The purpose of this study was to systematically evaluate the prognosis of patients with hepatocellular carcinoma (HCC) smaller than 5 cm using microwave ablation (MWA) versus radiofrequency ablation (RFA). PubMed, Cochrane Library and Embase databases were searched for studies reporting comparisons of two interventions (MWA versus RFA) for patients with early-stage HCC published up to 31 December, 2022. The analysis evaluated the recurrence-free survival (RFS), overall survival (OS) and complications. A total of 894 patients were enrolled in six studies (two randomised controlled trials and four propensity score cohort studies). There were 446 patients in the MWA group and 448 patients in the RFA group. Compared with RFA, MWA had a significant advantage in the post-operative 1-, 2-, 3- and 5-year RFS (odds ratios [OR] = 0.58, 95% confidence interval [CI]: 0.40, 0.84; OR = 0.60, 95% CI: 0.45, 0.80; OR = 0.56, 95% CI: 0.33, 0.93; and OR = 0.44, 95% CI: 0.30, 0.65). The OS of MWA was significantly higher than that of RFA in 5 years after ablation (OR = 0.48, 95% CI: 0.34, 0.68). Moreover, MWA had an advantage in the incidence of complications (OR = 2.23, 95% CI: 1.16, 4.29). In the comparison of percutaneous MWA and RFA in the treatment of HCC with a diameter smaller than 5 cm, MWA may have more advantages in improving the prognosis. |
format | Online Article Text |
id | pubmed-10695319 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-106953192023-12-05 Microwave ablation is superior to radiofrequency ablation in the treatment of hepatocellular carcinoma below 5 cm - A systematic review and meta-analysis Zhang, Lingkai Du, Fei Zhang, Yongxuan Yangdan, Cairang Wang, Haijiu Ren, Li J Minim Access Surg Review Article The purpose of this study was to systematically evaluate the prognosis of patients with hepatocellular carcinoma (HCC) smaller than 5 cm using microwave ablation (MWA) versus radiofrequency ablation (RFA). PubMed, Cochrane Library and Embase databases were searched for studies reporting comparisons of two interventions (MWA versus RFA) for patients with early-stage HCC published up to 31 December, 2022. The analysis evaluated the recurrence-free survival (RFS), overall survival (OS) and complications. A total of 894 patients were enrolled in six studies (two randomised controlled trials and four propensity score cohort studies). There were 446 patients in the MWA group and 448 patients in the RFA group. Compared with RFA, MWA had a significant advantage in the post-operative 1-, 2-, 3- and 5-year RFS (odds ratios [OR] = 0.58, 95% confidence interval [CI]: 0.40, 0.84; OR = 0.60, 95% CI: 0.45, 0.80; OR = 0.56, 95% CI: 0.33, 0.93; and OR = 0.44, 95% CI: 0.30, 0.65). The OS of MWA was significantly higher than that of RFA in 5 years after ablation (OR = 0.48, 95% CI: 0.34, 0.68). Moreover, MWA had an advantage in the incidence of complications (OR = 2.23, 95% CI: 1.16, 4.29). In the comparison of percutaneous MWA and RFA in the treatment of HCC with a diameter smaller than 5 cm, MWA may have more advantages in improving the prognosis. Wolters Kluwer - Medknow 2023 2023-07-05 /pmc/articles/PMC10695319/ /pubmed/37706417 http://dx.doi.org/10.4103/jmas.jmas_344_22 Text en Copyright: © 2023 Journal of Minimal Access Surgery https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Review Article Zhang, Lingkai Du, Fei Zhang, Yongxuan Yangdan, Cairang Wang, Haijiu Ren, Li Microwave ablation is superior to radiofrequency ablation in the treatment of hepatocellular carcinoma below 5 cm - A systematic review and meta-analysis |
title | Microwave ablation is superior to radiofrequency ablation in the treatment of hepatocellular carcinoma below 5 cm - A systematic review and meta-analysis |
title_full | Microwave ablation is superior to radiofrequency ablation in the treatment of hepatocellular carcinoma below 5 cm - A systematic review and meta-analysis |
title_fullStr | Microwave ablation is superior to radiofrequency ablation in the treatment of hepatocellular carcinoma below 5 cm - A systematic review and meta-analysis |
title_full_unstemmed | Microwave ablation is superior to radiofrequency ablation in the treatment of hepatocellular carcinoma below 5 cm - A systematic review and meta-analysis |
title_short | Microwave ablation is superior to radiofrequency ablation in the treatment of hepatocellular carcinoma below 5 cm - A systematic review and meta-analysis |
title_sort | microwave ablation is superior to radiofrequency ablation in the treatment of hepatocellular carcinoma below 5 cm - a systematic review and meta-analysis |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695319/ https://www.ncbi.nlm.nih.gov/pubmed/37706417 http://dx.doi.org/10.4103/jmas.jmas_344_22 |
work_keys_str_mv | AT zhanglingkai microwaveablationissuperiortoradiofrequencyablationinthetreatmentofhepatocellularcarcinomabelow5cmasystematicreviewandmetaanalysis AT dufei microwaveablationissuperiortoradiofrequencyablationinthetreatmentofhepatocellularcarcinomabelow5cmasystematicreviewandmetaanalysis AT zhangyongxuan microwaveablationissuperiortoradiofrequencyablationinthetreatmentofhepatocellularcarcinomabelow5cmasystematicreviewandmetaanalysis AT yangdancairang microwaveablationissuperiortoradiofrequencyablationinthetreatmentofhepatocellularcarcinomabelow5cmasystematicreviewandmetaanalysis AT wanghaijiu microwaveablationissuperiortoradiofrequencyablationinthetreatmentofhepatocellularcarcinomabelow5cmasystematicreviewandmetaanalysis AT renli microwaveablationissuperiortoradiofrequencyablationinthetreatmentofhepatocellularcarcinomabelow5cmasystematicreviewandmetaanalysis |